Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 28(8): 1287-1291, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29559277

ABSTRACT

Previously we have shown that pentacycloundecylamine-chloroquinoline (PCU-CQ) conjugates possess significant chemosensitizing abilities and can circumvent the resistance associated with chloroquine (CQ) resistant plasmodia. In order to further explore structurally related polycyclic compounds as reversed CQ agents we synthesized a series of eight aza-adamantanol (1-4) and adamantane-imine (5-8) CQ conjugates. All conjugates showed limited cytotoxicity against CHO cells (IC50 > 37 µM). Compounds 1, 2 and 5 were highly active (K1 IC50 < 100 nM) exhibiting a 3-4-fold increase in antiplasmodial activity against CQ resistant strain K1 compared to CQ. Reduced cross-resistance (resistance index, RI: 2-4.3) relative to CQ (RI = 38) was also observed for these compounds. Compound 1 which showed an 18-fold enhancement at retaining its activity against the K1 strain compared to CQ is a promising candidate to substitute CQ in P. falciparum resistant malaria.


Subject(s)
Adamantane/analogs & derivatives , Adamantane/pharmacology , Aminoquinolines/pharmacology , Antimalarials/pharmacology , Drug Resistance, Microbial/drug effects , Plasmodium falciparum/drug effects , Adamantane/chemical synthesis , Adamantane/chemistry , Aminoquinolines/chemical synthesis , Aminoquinolines/chemistry , Aminoquinolines/toxicity , Animals , Antimalarials/chemical synthesis , Antimalarials/chemistry , Antimalarials/toxicity , CHO Cells , Cricetulus , Erythrocytes/microbiology , Humans , Inhibitory Concentration 50 , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...